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Abstract
Four-stranded G-quadruplex DNA secondary structures have recently been visualized in the nuclei of human cultured cells.
Here, we show that BG4, a G-quadruplex-specific antibody, can be used to stain DNA G-quadruplex structures in patient-
derived tissues using immunohistochemistry. We observe a significantly elevated number of G-quadruplex-positive nuclei in
human cancers of the liver and stomach as compared to background non-neoplastic tissue. Our results suggest that G-
quadruplex formation can be detected and measured in patient-derived material and that elevated G-quadruplex formation
may be a characteristic of some cancers.
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Introduction
Non-canonical G-quadruplex DNA secondary structures can be
formed from guanine-rich DNA sequences of the type G3+NL1
G3+NL2 G3+NL3 G3+(N= any base and L= loop) and such
sequence motifs are prevalent throughout the human genome
[1,2]. G-quadruplexes are four-stranded structures that comprise
stacks of tetrads formed through Hoogsteen hydrogen-bonding of
four guanines coordinated by a central monovalent cation [3].
Oligonucleotides folded into a G-quadruplex structure in vitro have
a high thermodynamic stability under near-physiological condi-
tions, consistent with their formation in cells [4]. The predicted
location of G-quadruplex sequence motifs in regulatory regions of
the genome, such as promoters and telomeres, suggests that G-
quadruplex structures may have important roles in genome
function [5–7]. A number of helicases that resolve G-quadruplexes
have been identified and are hypothesized to contribute to normal
genome functions, such as replication, transcription and the
maintenance of genome stability [8]. The visualization of DNA G-
quadruplex structures in human cells has supported the existence
of G-quadruplexes in the genome [9]. In these experiments, a
highly selective G-quadruplex-specific antibody (BG4) was gener-
ated by phage display and employed to visualize discrete foci of G-
quadruplex structures in the nuclei of human tissue culture cell
lines. This antibody has provided an opportunity to probe the
cellular role of G-quadruplexes and also their potential involve-
ment in disease.
G-quadruplex structures have been suggested to be associated
with cellular functions such as replication and transcription. For
example, G-quadruplex stabilization by a small molecule can
repress transcription of certain oncogenes and/or induce DNA
damage at telomeres and oncogenes leading to replication defects
and cell death [10–17]. G-quadruplex structures may also be
linked to genome instability and G-quadruplex sequence motifs
have been found proximal to DNA breakpoints and sites of
somatic copy number changes seen in several cancers [18,19].
Helicases that resolve G-quadruplexes are also found localized at
sites of genome instability [20–22], and diseases such as Bloom’s
and Werner’s syndromes, which show increased levels of genome
instability and a predisposition to cancer, have contributing
mutations in G-quadruplex-resolving helicases [23].
Given the potential relationship between G-quadruplex struc-
tures and human disease, it is an important goal to address
whether G-quadruplexes can be detected within human tissues.
We therefore investigated the detection of DNA G-quadruplexes
in patient-derived tissues and whether there are differences in G-
quadruplex levels between non-neoplastic and cancer tissues. By
employing the G-quadruplex-specific antibody, BG4, in immuno-
histochemistry with formalin-fixed paraffin-embedded (FFPE)
tissue microarray sections, we have detected widespread DNA
G-quadruplex formation in the nuclei of human tissues. Quanti-
fication of BG4-positive cell nuclei revealed more extensive
formation of G-quadruplex structures in stomach and liver cancers
compared to the corresponding background non-neoplastic tissues.
These results suggest that processing of G-quadruplex structures is
mis-regulated in some human cancers.
Results and Discussion
We set out to demonstrate the presence of G-quadruplexes in
the nuclei of human tissues and to investigate whether any
differences are readily apparent in patient-derived cancer tissues.
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Our approach was based on the detection of nuclear G-
quadruplexes by immunohistochemistry (IHC) with the G-
quadruplex-specific antibody, BG4, on non-neoplastic and cancer
tissue microarrays (TMAs). The specificity and selectivity of BG4
for G-quadruplex structures and the application of BG4 in
immunofluorescence (IF) microscopy on human cells have been
previously described [9]. To determine the suitability of BG4 for
IHC, we first tested this antibody in a model system using sections
from FFPE cell pellets of MDA-MB-231 breast cancer cells that
were previously observed to display nuclear G-quadruplex foci by
IF microscopy [9]. As epitope retrieval, either heat-mediated (in
citrate-based pH 6.0 or Tris/EDTA-based pH 9.0 buffers) or
enzymatic (with proteinase K), is often required to expose
antigenic sites before antibody binding, we compared these three
standard epitope retrieval pre-treatments. After BG4 incubation,
staining was performed by incubation with a secondary anti-
FLAG antibody, which recognizes a FLAG tag epitope present in
the BG4 antibody, followed by Leica horseradish peroxidase
polymer-based detection using the Bond IHC staining platform.
Following this protocol, intense nuclear staining was observed with
BG4 only after epitope retrieval (Figure 1B and S1). No staining
was observed in the absence of pre-treatment (Figure 1A) and
controls performed in the absence of BG4 showed that epitope
retrieval with citrate-based buffer gave less background than that
with Tris/EDTA (Figure 1C and S1), whereas pre-treatment with
proteinase K led to non-specific nuclear staining even in the
absence of BG4 (Figure S1). Moreover, after epitope retrieval with
citrate or Tris/EDTA buffers, DNase I treatment prior to BG4
staining led to a strong reduction in BG4 nuclear signal intensity
(Figure 1D and S1), further confirming the detection of DNA G-
quadruplexes. The nuclear BG4 signal seen in IHC is consistent
with the previous detection of BG4 foci in the nuclei of tissue
culture cells [9].
Having established an IHC protocol for BG4, we first confirmed
that biopsied non-neoplastic human tissue samples could be
stained using BG4. Generally, we observed varied BG4 staining
patterns across many tissues suggesting differences in the
formation of G-quadruplexes between tissues and also between
cells within the same tissue (Figure S2). These results indicate that
the overall formation of DNA G-quadruplexes in complex human
tissues can be assessed using BG4 in IHC, thereby extending the
visualization of G-quadruplex structures beyond IF microscopy in
tissue culture cells. In a provisional survey of BG4 staining on
cancer tissues compared with background non-neoplastic tissue,
differences in BG4 staining intensity or distribution appeared
mostly inconclusive (data not shown), and in many cases rigorous
quantification was not possible due to significant differences in
morphology and presence of multiple cell types in malignant
versus non-neoplastic tissue. In contrast, for liver and stomach, our
provisional examination suggested that these tissues were readily
quantifiable due to a more uniform appearance within and
between non-neoplastic and cancer tissues. We therefore used the
Aperio Imagescope Nuclear (v9) image analysis software to
quantify the percentage of BG4-positive nuclei present in the
TMAs. A separate image analysis classifier was developed for each
tissue type to accurately identify and separate touching objects,
with the malignant and non-neoplastic samples scored using the
same parameters for accurate comparison. Strikingly, in nine cases
for which we had duplicate liver cancer TMA cores with the
corresponding matched background non-neoplastic tissue taken
from the same patient, we observed a far greater number of BG4-
positive nuclei in cancer (mean 60.365.4%) versus non-neoplastic
(mean 18.362.12%) tissue cores (Figure 2). When individual
cancer phenotypes were examined, we found that both hepato-
cellular carcinoma (HCC) and intrahepatic cholangiocarcinoma
(ICC) showed significantly greater nuclear BG4 staining compared
to non-neoplastic tissue (Figure 2A–D and G). Although HCC and
ICC have different cellular origins, developing from hepatocytes
or bile duct cholangiocytes respectively, both showed a greater
number and intensity of BG4-positive nuclei compared to the non-
neoplastic liver tissue. Furthermore, in metastases (isolated from
large cell undifferentiated lung carcinoma sites) an increase in
BG4-positive staining was also noted (Figure 2E–G). We observed
clear differences between non-neoplastic and tumor tissue for a
number of different patient cases. Indeed, a wider-ranging analysis
of cancer and background non-neoplastic TMA cores including
unmatched cases again showed an increase in BG4-positive nuclei
across HCC, ICC and metastatic carcinoma (Figure 3A). When all
cases were considered together, a ,2.4-fold increase in the
number of BG4-positive nuclei was seen in liver cancer compared
to non-neoplastic tissue (P,0.001, Figure 3B).
Similar to the increase of G-quadruplex incidence in liver
cancer tissue, a greater than 3-fold increase in the number of BG4-
positive nuclei was observed in stomach adenocarcinoma and
signet ring cell carcinoma compared with background non-
neoplastic tissue taken from the same individual (Figure 4). A
wider-ranging analysis of stomach cancer and non-neoplastic
tissues including unmatched cases reaffirmed the increase in the
number of BG4-positive nuclei seen in stomach cancer compared
with non-neoplastic tissue (Figure 5). Indeed, in individual
stomach cancer sub-types, adenocarcinomas (originating from
glandular epithelia), signet ring cell carcinomas (adenocarcinomas
characterized by mucin deposition) and gastrointestinal stromal
tumors (GIST, KIT-expressing sarcomas of mesenchymal origin),
all showed greater number of BG4-positive nuclei compared to
non-neoplastic stomach tissue (Figure 5A). When all cases were
considered together, ,3.1-fold more BG4-positive nuclei were
found in cancer versus non-neoplastic tissues (Figure 5B, P,
0.001). It is notable that several stomach tumor sub-types, which
have different etiologies and progression, are all characterized by
increase in BG4 staining. These results are therefore highly
suggestive of a general link between an increased presence of G-
quadruplex structures and stomach cancer development.
In the liver and stomach TMAs, some cancer tissue cores
showed little or no quantifiable BG4 staining, perhaps reflecting
an issue in epitope stability during surgical biopsy collection or
alternatively pointing to a real variability in G-quadruplex
formation in these particular tissues. It is nevertheless of note that
in no case was any non-neoplastic liver or stomach tissue
extensively BG4-positive. This latter observation further confirms
that the increase in the number of BG4-positive cells seen in the
cancer TMA cores reflects a true difference in G-quadruplex
presence between the non-neoplastic and malignant states.
Analysis of G-quadruplex staining in other cancers may therefore
be possible and our preliminary analysis of pancreas tissue suggests
that, while BG4 staining in non-neoplastic pancreas is widespread,
there is a ,1.6-fold increase of BG4 nuclear staining in
adenocarcinoma tissues (P,0.01, Figure S3).
Overall, our results demonstrating that G-quadruplexes can be
visualized by IHC in non-neoplastic and cancer human tissues
extend our earlier findings that revealed the presence of G-
quadruplex structures in the nuclei of culture cell lines [9]. It is
noteworthy that we observed an increase in the number of G-
quadruplex-positive cells for some cancer tissues compared to non-
neoplastic cases. The data that we present do not in themselves
explain why more G-quadruplexes are apparent in the cases of
stomach and liver cancers. However, there are several lines of
evidence in the literature that suggest a potential association or
G-Quadruplexes and Cancer
PLOS ONE | www.plosone.org 2 July 2014 | Volume 9 | Issue 7 | e102711
causative link between G-quadruplexes and mechanisms contrib-
uting to cancer development or progression. For example, G-
quadruplex structures, if not resolved during DNA replication,
may represent fragile sites that promote genome instability, which
is a well-known hallmark of cancer [24]. Indeed, G-quadruplex
sequence motifs are found at DNA breakpoints that lead to
translocations within the BCL2 gene in lymphomas and within the
HOX11 gene in T-cell leukemias [25,26]. Computational analyses
have also suggested possible associations of G-quadruplexes and
breakpoint regions in various cancers [19].
We hypothesize that an increase in genomic G-quadruplexes in
cancer may arise from mutations in enzymes that process G-
quadruplexes and/or genomic instability at G-quadruplex sites.
For example, Fanconi anaemia, Bloom’s and Werner’s syndromes,
all display genome instability with a predisposition to cancer [27–
29] and result from mutations in DNA helicase enzymes that have
G-quadruplex-resolving activity [30–32]. Recent genome-wide
studies have also highlighted the recognition of G-quadruplex
sequences by additional resolving helicases such as ATRX, PIF1
and XPB/D [20–22]. Furthermore, PIF1 has been suggested to
suppress genomic instability at G-quadruplexes [22], while ATRX
loss is associated with chromosomal instability in pancreatic
neuroendocrine tumors [33], and XPD mutations disrupt nucle-
otide excision DNA repair that leads to cancer-prone diseases such
as Xeroderma pigmentosum [34].
It appears that liver and stomach cancers are highly heteroge-
neous and are not characterized by a common genetic signature or
a highly represented driving mutation that may simply explain the
observed increase in G-quadruplex structures. While many liver
cancers are associated with hepatitis B or C infection, the
pathological information obtained with the TMAs indicates that
there is no correlation with BG4 staining. As part of future work, it
will be of value to analyze non-neoplastic and malignant tumor
samples for cases where whole-genome sequencing has been
employed to elucidate the genetic background of the tumor/non-
neoplastic pairs, in order to establish the relationship between
genotype and G-quadruplex formation in cancer.
Figure 1. Validation of G-quadruplex nuclear staining by immunohistochemistry. A. Human MDA-MB-231 breast adenocarcinoma cell
pellets were fixed, paraffin embedded and processed for IHC using the G-quadruplex-specific antibody BG4. No staining is observed in the absence of
epitope retrieval. Scale bar corresponds to 20 mm. Nuclei are counterstained with haematoxylin (blue). B. Strong BG4 staining (brown) is readily
apparent in cell nuclei following antigen retrieval with citrate-based buffer pH 6.0. C. No staining is observed in the absence of the BG4 primary
antibody. D. No staining is seen following DNase treatment prior to BG4 staining. These results show that BG4 can be employed for DNA G-
quadruplex detection by IHC staining.
doi:10.1371/journal.pone.0102711.g001
G-Quadruplexes and Cancer
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In conclusion, we report the use of the G-quadruplex-specific
antibody, BG4, in IHC staining experiments of human non-
neoplastic and cancer tissues. This study has enabled us to identify
a significantly higher presence of DNA G-quadruplex structures in
the nuclei of stomach and liver cancer cells compared to the
corresponding non-neoplastic tissues. We hypothesize that these
differences might be dependent on alterations of cellular processes
that regulate genome stability or changes in the chromatin state at
G-quadruplex sites in cancer tissues. Our results support the
possibility that cancer cells may provide a window of selectivity
that would make them more sensitive than non-neoplastic cells
towards a small molecule G-quadruplex-targeting strategy.
Figure 2. Increased incidence of DNA G-quadruplex structures in human liver cancer relative to matched non-neoplastic tissue.
Background non-neoplastic and cancer liver tissues were stained by IHC using the G-quadruplex-specific antibody BG4. A. The nuclei of non-
neoplastic liver tissue from a hepatocellular carcinoma patient are mostly BG4-negative, with haematoxylin counterstaining (blue) evident. Scale bar
corresponds to 50 mm. Note that the cytoplasmic granules are variable and likely to be heme-based artifacts sometimes observed in liver IHC. B.
Neoplastic tissue from the same patient in A shows the extensive presence of BG4-positive nuclei (brown). C. The nuclei of non-neoplastic liver tissue
for an intrahepatic cholangiocarcinoma patient are mostly BG4-negative. D. Neoplastic tissue from the same patient in C shows many BG4-positive
nuclei. E. The nuclei of non-neoplastic liver tissue from a metastatic large cell undifferentiated lung carcinoma patient are mostly BG4-negative. F.
Metastatic liver tissue isolated from the same patient in E shows many BG4-positive nuclei. G. Quantification of the number of BG4-positive nuclei in
liver cancer and corresponding matched non-neoplastic tissues from nine patients. Error bars represent the standard error of the mean (s.e.m.)
calculated when duplicate TMA cores were available. Overall, these results indicate that there are a greater number of G-quadruplex structures in liver
cancer compared to background non-neoplastic tissue from the same individual.
doi:10.1371/journal.pone.0102711.g002
Figure 3. Increased incidence of G-quadruplex-positive cell nuclei across human liver cancers. A. Quantification of the number of BG4-
positive nuclei in individual liver tissues including unmatched TMA cores. Non-neoplastic liver shows less BG4-positive nuclei compared to
hepatocellular carcinoma or intrahepatic cholangiocarcinoma. Each column corresponds to a single tissue sample and error bars represent the s.e.m.
calculated when duplicate tissue samples were available. B. Overall quantification of the number of BG4-positive nuclei in all non-neoplastic and
cancer liver tissues. Error bars represent the s.e.m. **P,0.001, n = 19 and 32 for non-neoplastic and cancer cores, respectively. These results confirm
the generality of more extensive G-quadruplex formation in the liver cancers compared to non-neoplastic tissues.
doi:10.1371/journal.pone.0102711.g003
G-Quadruplexes and Cancer
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Materials and Methods
Fixation, embedding, sectioning and staining of cell pellets were
performed by the histopathology core service at the Cancer
Research UK Cambridge Institute. Immunohistochemistry (IHC)
was performed using standard methods on an automated Leica
Bond platform with minor variations. Briefly, tissues were fixed for
24 h at room temperature (RT) in 10% neutral buffered formalin
and processed using a Leica ASP300 tissue processor with de-
hydration through a graded ethanol series, clearing in xylene and
infiltration with molten paraffin wax. Embedding was performed
on a Leica EG1160 Embedding Station and sections were cut at
3 mm with a microtome, floated on a water bath set at ,45–50uC
until smooth and flat, before collection on a microscope slide and
Figure 4. Increased incidence of DNA G-quadruplex structures in human stomach cancer relative to matched non-neoplastic tissue.
Gastric adenocarcinoma and signet ring cell carcinoma and matched background non-neoplastic tissues taken from the same patient were stained
with the G-quadruplex-specific antibody BG4 by IHC. A. The nuclei of non-neoplastic stomach tissue from a gastric adenocarcinoma patient are
mostly BG4-negative, with haematoxylin counterstaining (blue) readily apparent. Scale bar corresponds to 50 mm. B. Adenocarcinoma tissue from the
same patient in A shows extensive numbers of BG4-positive nuclei (brown). C. The nuclei of non-neoplastic stomach tissue from a signet ring cell
carcinoma patient are mostly BG4-negative. D. Signet ring cell carcinoma tissue from the same patient in C shows many BG4-positive nuclei. E.
Quantification of the number of BG4-positive nuclei in the matched stomach cancers and background non-neoplastic tissues from two different
patients. Error bars represent the s.e.m. calculated when duplicate TMA cores were available. These results indicate that there are more G-quadruplex
structures in the nuclei of stomach cancer tissue than in non-neoplastic tissue from the same individual.
doi:10.1371/journal.pone.0102711.g004
Figure 5. Increased incidence of G-quadruplex-positive cell nuclei across human stomach cancers. Confirmation of the increased
presence of BG4-positive nuclei in a range of stomach cancer tissues compared to background non-neoplastic tissues including unmatched cases. A.
The nuclei of non-neoplastic stomach tissues are largely BG4-negative. Cell nuclei were counterstained with haematoxylin (blue). Scale bar
corresponds to 50 mm. B. Gastric adenocarcinoma tissue shows the extensive presence of BG4-positive nuclei (brown). C. Signet ring cell carcinoma
shows many BG4-positive nuclei. D. Gastrointestinal stromal tumors (GIST) are largely BG4-positive (for the survey of stomach cancer only unmatched
GIST tissues were available). E. Quantification of the number of BG4-positive nuclei in individual stomach tissues including unmatched TMA cores.
Non-neoplastic stomach tissue shows less BG4-positive nuclei compared to adenocarcinoma, signet ring carcinoma or GIST. Each column
corresponds to a single tissue sample and error bars represent the s.e.m. calculated when duplicate tissue samples were available. F. Overall
quantification of the number of BG4-positive nuclei in all non-neoplastic and stomach liver tissues. Error bars represent the s.e.m. **P,0.001, n = 10
and 34 for non-neoplastic and cancer cores, respectively. These results confirm the generality of more extensive G-quadruplex formation in the
stomach cancers compared t-o non-neoplastic tissues.
doi:10.1371/journal.pone.0102711.g005
G-Quadruplexes and Cancer
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drying at 60uC for 1 h. De-waxing and re-hydration were
performed using an automated Leica ST5020 multistainer.
MDA-MB-231 human breast adenocarcinoma cells were obtained
from ATCC LGC Standards. For MDA-MB-231 cell pellets,
epitope retrieval was performed at 100uC for 20 min with Bond
epitope retrieval Solution 1 (citrate-based buffer pH 6.0) or Bond
epitope retrieval solution 2 (Tris/EDTA-based buffer pH 9.0) or at
37uC for 10 min with Bond enzyme pre-treatment kit (100 mg/ml
proteinase K in Tris-buffered saline, surfactant and 0.35% ProClin
950) to find the best condition. Commercially available human
tissue microarrays with appropriate ethical approval in the country
of origin were purchased from Insight Bio UK (for US Biomax
Inc. arrays) and BioCat, Germany or Stretton Scientific, UK (for
Accumax, Isu Abxis arrays). Epitope retrieval was performed at
100uC for 20 min with citrate buffer. BG4 staining was performed
at RT on an automated Leica Bond instrument with a rabbit
polymer kit (Leica) following a 15 min incubation with BG4 and a
8 min incubation with an anti-FLAG rabbit polyclonal antibody
(Cell Signaling Technology). Slides were then counterstained for
5 min with 0.02% haematoxylin to visualize the cell nuclei. De-
hydration and clearing were done on an automated Leica ST5020
multistainer, and mounting was performed on an automated glass
coverslipper Leica CV5030. Slides were scanned with an Aperio
XT120 slide scanning system (Leica) and images analyzed using
the Aperio Imagescope Nuclear v9 software. Statistical analyses
and P values were calculated using the Student’s t-test. Frequency-
distribution graphs were plotted using GraphPad Prism (Graph-
Pad Software).
Supporting Information
Figure S1 BG4 staining on paraffin-embedded MDA-
MB-231 cell pellets. A. Human MDA-MB-231 breast cancer
cell pellets were fixed, paraffin-embedded and processed for IHC
using the G-quadruplex-specific antibody BG4. Strong BG4
staining (brown) is apparent in cell nuclei following epitope
retrieval with Tris/EDTA-based buffer pH 9.0. Scale bar
corresponds to 20 mm. Nuclei are counterstained with haematox-
ylin (blue). B. Strong BG4 staining (brown) is apparent in cell
nuclei following epitope retrieval with proteinase K. C. No nuclear
staining is observed in the absence of the BG4 antibody after Tris/
EDTA epitope retrieval. D. No nuclear staining is seen following
DNase treatment prior to BG4 staining after epitope retrieval with
EDTA. E. High levels of non-specific staining in the absence of
BG4 after epitope retrieval with proteinase K.
(TIF)
Figure S2 Non-neoplastic human tissues show variable
BG4 staining. Non-neoplastic tissues were stained by IHC using
the G-quadruplex-specific antibody BG4. A. BG4 staining (brown)
in the kidney cortex shows a range of nuclear staining intensities in
glomeruli and associated structures. Cell nuclei were counter-
stained with haematoxylin (blue). Scale bar corresponds to 50 mm
B. Weakly positive BG4 staining is seen in the collecting tubule
nuclei of the kidney medulla. C. Skin shows a range of BG4
intensities in the epidermis with positive and negative nuclei
scattered throughout, whereas the dermis is mostly positive. D.
Most nuclei in colon are BG4-positive. E. In the uterine body, the
stratified squamous epithelium is largely BG4-negative whereas
positive staining is seen more superficially. F. Throughout the
breast ductal lobules, both myoepithelial and luminal cells show
general strong BG4 staining with only occasional negative cells.
(TIF)
Figure S3 Elevated presence of G-quadruplex struc-
tures in human pancreas cancer tissues. Non-neoplastic
and cancer pancreatic tissues were stained by IHC using the G-
quadruplex-specific antibody BG4, and the number of BG4-
positive nuclei was scored using Aperio Imagescope software. A.
The nuclei of non-neoplastic pancreas tissue show moderate BG4
staining (brown) with many unstained nuclei also present. Cell
nuclei were counterstained with haematoxylin (blue). Scale bar
corresponds to 50 mm. B. BG4 staining in pancreatic adenocar-
cinoma tissue is more extensive with greater intensity. C. Overall
quantification of the number of BG4-positive nuclei across all non-
neoplastic and pancreatic cancer tissues. Error bars represent the
s.e.m. *P,0.01, n= 6 and 12 for non-neoplastic and cancer cores,
respectively.
(TIF)
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